drugset / Trial / NCT00348582

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

NCT00348582

Phase 4 Completed Innovative Medical
RandomizedParallel-groupSingle-blind

Summary

The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified
Subject Nepafenac Other / unclassified

Indications